A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Thiamylal
Rifaximin
The serum concentration of Rifaximin can be increased when it is combined with Tariquidar.
Thiamylal
Prucalopride
The serum concentration of Prucalopride can be increased when it is combined with Tariquidar.
Thiamylal
Pazopanib
The serum concentration of Pazopanib can be increased when it is combined with Tariquidar.
Thiamylal
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Tariquidar.
Thiamylal
Ledipasvir
The serum concentration of Ledipasvir can be increased when it is combined with Tariquidar.
Thiamylal
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Tariquidar.
Thiamylal
Brentuximab vedotin
The serum concentration of Brentuximab vedotin can be increased when it is combined with Tariquidar.
Thiamylal
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Tariquidar.
Thiamylal
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Tariquidar.
Sertaconazole
Satralizumab
The serum concentration of Rivaroxaban can be decreased when it is combined with Satralizumab.
Sertaconazole
Abametapir
The serum concentration of Rivaroxaban can be increased when it is combined with Abametapir.
Sertaconazole
Capmatinib
The serum concentration of Rivaroxaban can be increased when it is combined with Capmatinib.
Sertaconazole
Tucatinib
Rivaroxaban may decrease the excretion rate of Tucatinib which could result in a higher serum level.
Sertaconazole
Tafamidis
The serum concentration of Rivaroxaban can be increased when it is combined with Tafamidis.
Sertaconazole
Darolutamide
The serum concentration of Rivaroxaban can be increased when it is combined with Darolutamide.
Sertaconazole
Cenobamate
The serum concentration of Rivaroxaban can be decreased when it is combined with Cenobamate.
Sertaconazole
Lasmiditan
The serum concentration of Rivaroxaban can be increased when it is combined with Lasmiditan.
Sertaconazole
Nintedanib
The risk or severity of bleeding can be increased when Rivaroxaban is combined with Nintedanib.
Sertaconazole
Erdafitinib
The serum concentration of Rivaroxaban can be increased when it is combined with Erdafitinib.
Sertaconazole
Omega-3-acid ethyl esters
The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Rivaroxaban.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3